Non-Hodgkin Lymphoma Research and Clinical Trials

Physicians and scientists from Fred Hutch Cancer Center and UW Medicine are testing new treatments for non-Hodgkin lymphoma (NHL) and discovering new ways to use current NHL treatments. Through this work, we are looking for answers to two main questions:

• How can we do even better at controlling or curing NHL? 
• How can we make treatments less toxic and easier on patients? 

We have clinical trials for all stages of NHL, from early to advanced. These trials test dozens of medicines for different NHL subtypes. Some of the therapies we are studying are: 

• Chemotherapy regimens 
• Small molecule inhibitors 
• Immunotherapies, including cellular immunotherapies, antibody-based treatments and immune checkpoint inhibitors 
• Blood and marrow transplantation, which Fred Hutch researchers pioneered, including ways to prevent and treat complications

When your care team designs your treatment plan, they will give you the choice to join clinical trials that match your situation. If you decide to join one, you will see the same providers and nurses as you would for standard therapy. Your care team will talk with you about whether you might want to join a particular study and why. This can help you make the decision that is best for you.